Page last updated: 2024-10-31

ml 7 and Carcinoma, Lewis Lung

ml 7 has been researched along with Carcinoma, Lewis Lung in 1 studies

ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kim, YE1
Gwak, SH1
Hong, BJ1
Oh, JM1
Choi, HS1
Kim, MS1
Oh, D1
Lartey, FM1
Rafat, M1
Schüler, E1
Kim, HS1
von Eyben, R1
Weissman, IL1
Koch, CJ1
Maxim, PG1
Loo, BW1
Ahn, GO1

Other Studies

1 other study available for ml 7 and Carcinoma, Lewis Lung

ArticleYear
Effects of Ultra-high doserate FLASH Irradiation on the Tumor Microenvironment in Lewis Lung Carcinoma: Role of Myosin Light Chain.
    International journal of radiation oncology, biology, physics, 2021, 04-01, Volume: 109, Issue:5

    Topics: Animals; Azepines; Blood Vessels; Carcinoma, Lewis Lung; CD8-Positive T-Lymphocytes; Histones; Male;

2021